期刊文献+

不同化疗方式在晚期复治肿瘤治疗中的作用及分析 被引量:1

Observation and evaluation of efficacy of different methods of chemotherapy in retreatment of advanced malignant tumor patients
下载PDF
导出
摘要 目的探讨化疗在晚期复治肿瘤患者治疗中的作用及不同化疗方式的应用意义。方法以回顾性研究方式收集整理了259例患者的临床资料,按接受不同治疗分为介入化疗组(A组)、减量热化疗组(B组)、常规静脉化疗组(C组),比较在不同肿瘤之间各组的临床总有效率、中位生存期(MST)及总生存率。结果A、B、C组肿瘤有效率分别为31.2%、20.0%和6.2%(A、B组与C组相比,P<0.01),中位生存期分别为6.20、9.87和6.78个月。3组近期生存率差异无显著性,但23年生存率以热化疗(B组)为高,分别为33.3%及12.5%。结论单纯静脉化疗肿瘤缓解率较低,介入化疗有效率较高,但并不一定延长生存率;减量热化疗在提高复治患者的有效率,延长生存期方面有积极意义。 Objective To study the efficacy and significance of different methods of chemotherapy in treating malignant tumor. Methods 259 cases were divided into 3 groups according to different chemotherapy methods: the group of interventional chemotherapy ( A), whole body hyperthermia combined with chemotherapy (B) and only chemotherapy ( C ), for comparing response rate (RR) of the tumour, median survival time (MST), and overall survival rate. Results the RR in group A, B, C were 31.2% ,20.0% and 6.2% respectively( groups A and B compared with group C, P 〈 0.01 ). The MST were 6.20 months, 9.87 months and 6.78 months respectively. The short-term survival rate had no significant difference,but survival rates in 2-3 years were 33.3% and 12.5% ,with highest in group B. Conclusion The RR in only chemotherapy group was lower than other 2 groups. The RR in interventional chemotherapy group is highest, but the survival rate was not prolonged by treatment with interventional chemotherapy, and whole body hyperthermia combined with chemotherapy has active significance in improving response rate and prolonging the survival time of the patients with advanced tumor having been treated previously.
出处 《中国肿瘤临床与康复》 2006年第6期506-508,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肿瘤 介入化疗 热化疗 常规化疗 Neoplasms Interventional chemotherapy Whole body hyperthermia combined with chemotherapy Conventional chemotherapy
  • 相关文献

参考文献7

  • 1曹小龙,蔡小玲,郭添胜.支气管动脉灌注顺铂和长春花碱酰胺治疗难治性局部进展期NSCLC[J].中国肺癌杂志,2000,3(2):136-137. 被引量:5
  • 2单鸿 罗鹏飞 李彦豪 等.临床介入治疗学[M].广州:广东科技出版社,1997..
  • 3Ismailzade RS,Zharrid EA,Potapnev MP.Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma pediatr blood[J].Cancer,2005,44(7):79-81.
  • 4Vander Zee J.Heating the patient:a approach[J]?Am Oncol,2002,13 (8)1173-1184.
  • 5TaRahashi I,Zmi Y,Hasuda S,et al.Clincal application of hyperthermia combined with anticancer drugs for treatment of solid tumors[J].Surgery,2002,131(15):78-81.
  • 6Afanackovic D,Nierhaus A,Neumeier m,et al.The whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases[J].Cancer Immunol Immunother,2002,51 (11):603-613.
  • 7Dieing A,Ahlers O,Kerner T,et al.Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes[J].Immunobiology,2003,207(4):265-273.

二级参考文献2

共引文献55

同被引文献19

  • 1李新娉,虞喜豪,武文森,周建梁.大功率微波全身热疗与化疗联合应用治疗晚期肿瘤的临床观察[J].肿瘤,2007,27(1):67-69. 被引量:9
  • 2姜玉石,邹庆华.化疗联合内生场热疗治疗骨转移癌35例疗效分析[J].中国骨肿瘤骨病,2007,6(5):290-292. 被引量:3
  • 3汤钊猷.现代肿瘤学[M],3版.北京:人民卫生出版社,2012:543-547.
  • 4Wust P, Cho CH, Hildebrandt B ,et al. Thermal monitoring invasive, minimal - invasive and non - invasive approaches [ J]. Int J Hyper- thermia, 2006,22 : 255 - 262.
  • 5Christophi C, Winkworth A, Muralihdaran V, et al. The treatment of malignancy by hyperthermia [ J ]. Surg Oncol, 1998,7 : 83 - 90.
  • 6Rong Y, Mack P, Apoptosis induced by hyperthermia in dunn osteo- sarcoma cell line in vitro[ J]. Int J Hyperthermia, 2000,16 : 19 - 27.
  • 7Nikfarjam M, Muralidharan V, Malcontenti - wilson C, et al. The ap- optotic response of live and coloreetal live metastases to focal hyper- thermic injury[ J]. Anticancer Res ,2005 ,25 :1413 - 1419.
  • 8Sawaji Y, Sato T, Takeuchi A, et al. Anti - angiogenic action of hy- perthermia by suppressing gene expression and production of tumor - derived vascular endothelial growth factor in vivo and in vitro[ J]. Br J Cancer,2002,86 : 1597 - 1603.
  • 9Ried M, Potzger T, Braune N, et al. Cytoreductive surgery and hy- perthermic intrathoracic chemotherapy perfusion for malignant pleural tumor: periopertive management and clinical experience[J]. Eur Car- diothorac Sug,2013,43 (4) ; 801 - 807.
  • 10Westermann AM, Wiedemann GJ, Jager E, et al. A systemic hyper- thermia oncologic working group trial: Ifosfamide, carboplatin,and et- oposide combined with 41.8 degrees whole - body hyperthermia for metastatic soft tissue sarcoma[ J]. Oncology,2003,64 : 312 - 321.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部